When analyzing all tumors, higher T reg cell activity and increased expression of CDKN2A were associated with non-responsiveness within an individual patient, consistent with the known function of T reg cells in suppressing anti-tumor immune responses. This evidence concerns the gene CDKN2A and neoplasm.